‘hypoglycaemic events can accelerate cognitive decline’
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
While hypos are a familiar risk for diabetics, what is unfamiliar in the world of Alzheimer’s and dementia research is positive developments in treatment. Since the earliest forms of
dementia were discovered, they have proved a thorn in the side of researchers and scientists as study after study provided one brick wall after another in the hunt for an effective
treatment. Now, however, a new treatment has been described as a potential breakthrough. Known as lecanemab, the treatment has been found to slow cognitive decline by 27 percent in patients
who received the drug once every two weeks for 18 months. READ MORE: RAY MILLAND'S HEALTH 'BEGAN TO DETERIORATE' QUICKLY